Today's pre-market stock movers: CHWY, PATH, SNAP, HPE and more
Gainers:
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Comtech Telecommunications (CMTL.US)$ +2.7% (receives 5G contract with mobile network operator in Saudi Arabia)
• $ANI Pharmaceuticals (ANIP.US)$ +2.5% (receives FDA approval for ANDA for Fludrocortisone Acetate Tablets)
• $Silk Road Medical (SILK.US)$ +1.3% (CMS has expanded coverage for TCAR to include standard surgical risk patients within the VQI's TCAR
Analyst comments:
• $Americold Realty Trust (COLD.US)$ +1.4% (upgraded to Neutral from Underperform at BofA Securities)
Losers:
• $Immunic (IMUX.US)$ -62.2% (reported top-line data from its phase 2 CALDOSE-1 trial of lead asset, vidofludimus calcium)
• $Immunic (IMUX.US)$ -62.2% (reported top-line data from its phase 2 CALDOSE-1 trial of lead asset, vidofludimus calcium)
• $Centessa Pharmaceuticals (CNTA.US)$-8.9% (to discontinue clinical development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease)
• $Hewlett Packard Enterprise (HPE.US)$-5.5% (earnings and sales miss amid 'inflationary environment and ongoing supply-chain disruptions')
• $Concert Pharmaceuticals (CNCE.US)$ -5% (prices offering of 10 mln shares of common stock at $4.75 per share)
• $Magnolia Oil & Gas (MGY.US)$ -4.7% (announces proposed block trade of 7.5 mln Class A shares by selling shareholders; intends to purchase 2 mln Class B shares)
• $Blue Owl Capital (OWL.US)$ -3.1% (prices secondary offering by NBSH Blue Investments II of 10,698,180 shares of Class A common stock at $11.50 per share)
• $American Tower Corp (AMT.US)$-2.9% (intends to offer 8,350,000 shares of its common stock in a registered public offering)
• $International Game Technology (IGT.US)$-1.7% (signs ten year contract extension with Kansas lottery)
• $Moderna (MRNA.US)$ -1.4% (Moderna and EC to amend their originally agreed contractual delivery schedules for the Moderna COVID-19 vaccine booster product (Spikevax, mRNA-1273) or updated booster vaccine candidate)
• $Enochian Biosciences (ENOB.US)$ -1.2% (published on its website a letter to shareholders to clarify "several misrepresentations")
• $Radius Health (RDUS.US)$ -1.1% (provides update on abaloparatide transdermal system; to cease all work on abalo-TDS)
Analyst comments:
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment